Medical Research by Oliver E Bryd, Ed.D, M.D. of Stanford University (Excerpt) Published in Western Medicine Controlled test population using ŌNOX Foot Solution® had an advantage of nearly 3 to 1 in preventing and curing Athlete’s Foot. The older view was that Athlete’s Foot was highly contagious and resulted primarily from exposure to the causative organism. Preventive measures therefore consisted of using high-powered disinfectants in an attempt to sterilize the feet. The modern view is that the athlete’s foot results primarily from a lowered resistance of the skin to fungus spores that are nearly always present – regardless of efforts at sterilization. Accordingly, preventive measures must aim at restoring and maintaining the skin’s normal resistance to fungus attack. A reduction in the normal resistance of the skin is more important than exposure to a particular fungus as a course of athlete’s foot. The highest incidence of all tinea infections was found between the age of 11 and 40 years.
Medical Research by Dr. A.J. Salle, Head of the Department of Bacteriology - University of California at Los Angeles Dr. Salle studied the “skin toughener” (ŌNOX Foot Solution®) being sold as an athlete’s foot preventive. He found zinc chloride to be an astringent, a corrosive, and a mild antiseptic. The astringent action of zinc chloride was due to the action of the zinc ion in precipitating protein and that this action resulted in a contraction and toughening of the skin, which he concluded would make the latter more resistant to the action of a fungus. The product under investigation (ŌNOX) was relatively nontoxic to living tissue and could be repeatedly applied to the skin without harm, and that it made the skin a very unfavorable environment for the growth of fungus, so that even if the skin were infected with fungi, they would not grow or reproduce in sufficient numbers to cause athlete’s foot.
Preliminary Study on the Utilization of ŌNOX Solution for the Control of Bromhidrosis and Hyperhidrosis The California College of Podiatric Medicine and various podiatric practitioners’ offices have elected to utilize ŌNOX solution in the control of bromhidrosis, hyperhidrosis and chronic tinea pedis. This solution has been utilized over the last 10 months in the patient population of 77 patients, with satisfactory control of hydrosis and bromhidrosis achieved in 96 percent of the cases reviewed.